Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $34.5000 (1.47%) ($32.0000 - $36.0000) on Tue. Dec. 23, 2014. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.02% (three month average) | RSI | 35 | Latest Price | $34.5000(1.47%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -0.5% a day on average for past five trading days. | Weekly Trend | CAPR declines -3.5% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) JNK(7%) VT(7%) XLF(7%) EWG(6%) EWI(6%) | Factors Impacting CAPR price | CAPR will decline at least -2.01% in a week (0% probabilities). VIXM(-5%) TLT(-3%) SHY(-2%) GLD(-2%) BND(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.01% (StdDev 4.02%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $28.78(-16.58%) | Resistance Level | $37.33 | 5 Day Moving Average | $35.72(-3.42%) | 10 Day Moving Average | $36.28(-4.91%) | 20 Day Moving Average | $37.33(-7.58%) | To recent high | -18.8% | To recent low | 1.5% | Market Cap | $680m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |